Cardiac Surgical Procedures
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program1
Insulin infusion with a goalPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Novo NordiskInsulin infusion with a goal
CSL BehringFibrinogen concentrate
XVIVOColloid priming solution for ECC circuit
Clinical Trials (3)
Total enrollment: 463 patients across 3 trials
Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients
Start: Jul 2004Est. completion: May 2005400 patients
Phase 3Completed
Fibrinogen Concentrate In Children After Cardiac Surgery
Start: Aug 2010Est. completion: Nov 201163 patients
Phase 2Completed
Acute Kidney Injury After Cardiac Surgery
Start: Sep 2020Est. completion: Oct 2023
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space